Home > IPLJ > Vol. Volume XX > No. 1 (2009)
Keywords
Hatch-Waxman Act, generic biologics, biologics, drugs, Public Health Service Act, PHSA, patent, generic drugs, United States Food and Drug Administration, fda
Recommended Citation
Elysa B. Goldberg,
Fixing a Hole: Will Generic Biologics Find a Niche Within the Hatch-Waxman Act?,
20 Fordham Intell. Prop. Media & Ent. L.J. 327
(2009).
Available at: https://ir.lawnet.fordham.edu/iplj/vol20/iss1/6
COinS